Clinical Trial Update: Phase II CT-2103/Carboplatin in Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase II trial of CT-2103 in combination with carboplatin for ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CT-2103

Snippet

Sponsor: CTI BioPharma | Conditions: Ovarian Neoplasm | Phase 2 | Status: COMPLETED